Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
Background: The t:slim X2™ insulin pump with Control-IQ™ technology, an advanced hybrid closed-loop system, became available in the United States in early 2020. Real-world outcomes with use of this system have not yet been comprehensively reported. Methods: Individuals with type 1 diabetes (T1D) (≥1...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mary Ann Liebert Inc.
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |